Opexa Therapeutics to Present at September Conferences

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to Opexa Therapeutics to Present at September Conferences

Opexa Therapeutics (OPXA) Enters $5M Common Stock Purchase Agreement

September 1, 2015 6:23 AM EDT

Opexa Therapeutics (NASDAQ: OPXA) announced that the Company has entered into a stock purchase agreement with a private investor to fund the Companys NMO program, including its planned Phase I/II trial, for up to $5 million, upon achievement of certain pre-specified milestones.

The funding is to be provided in five tranches, based on the successful completion of milestones, with the first tranche having been delivered today, the effective date of this agreement. For the first tranche, the company issued shares priced at $0.55 per share for a purchase amount of $500,000. The total... More